
Merck & Co., Inc.
MRKNYSEHealthcare● Active
$118.85
$-1.94(-1.61%)
Market Cap$293.5B
P/E Ratio—
52W High$125.14
52W Low$76.66
Merck & Co., Inc. (MRK) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MRK · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $64.93B | $64.17B | $60.12B | $59.28B | $48.70B |
| Cost of Revenue | $18.20B | $15.19B | $16.13B | $17.41B | $13.63B |
| Gross Profit | $46.73B | $48.98B | $43.99B | $41.87B | $35.08B |
| Gross Margin %(computed) | 71.98% | 76.32% | 73.17% | 70.63% | 72.02% |
| Operating Expenses | |||||
| R&D Expenses | $12.51B | $17.94B | $30.53B | $13.55B | $12.24B |
| G&A Expenses | $0.00B | $7.70B | $7.58B | $7.47B | $7.40B |
| Total Operating Expenses | $23.25B | $28.75B | $41.03B | $23.59B | $21.88B |
| Operating Income | $23.49B | $20.22B | $2.95B | $18.28B | $13.20B |
| Operating Margin %(computed) | 36.17% | 31.51% | 4.91% | 30.84% | 27.10% |
| Interest Income | $0.34B | $0.41B | $0.36B | $0.16B | $0.04B |
| Interest Expense | $1.36B | $1.27B | $1.15B | $0.96B | $0.81B |
| Income Before Tax | $21.07B | $19.94B | $1.89B | $16.44B | $13.88B |
| Income Tax Expense | $2.80B | $2.80B | $1.51B | $1.92B | $1.52B |
| Net Income | $18.25B | $17.12B | $0.36B | $14.52B | $13.05B |
| Net Margin %(computed) | 28.12% | 26.68% | 0.61% | 24.49% | 26.79% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $7.30 | $6.76 | $0.14 | $5.73 | $5.16 |
| Wtd Avg Shares | 2.50B | 2.53B | 2.61B | 2.53B | 2.53B |
| EBITDA | $29.32B | $25.71B | $6.91B | $21.32B | $17.90B |
| EBITDA Margin %(computed) | 45.17% | 40.06% | 11.49% | 35.95% | 36.75% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Merck & Co., Inc. data
About Merck & Co., Inc. (MRK) Income Statement
Merck & Co., Inc. (MRK) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MRK reported revenue of $64.93B, gross profit of $46.73B (gross margin 71.98%), and net income of $18.25B — a net profit margin of 28.12%.
Frequently asked questions
MRK · 4 questionsMerck & Co., Inc. (MRK) reported revenue of $64.93B for 2025, up 1.2% year-over-year.
MRK revenueMRK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08